YOKNEAM, Israel, Aug. 8, 2012 /PRNewswire/ -- Syneron Medical Ltd.
(NASDAQ: ELOS), the leading global aesthetic device company,
announced today that Louis P.
Scafuri, Chief Executive Officer, is scheduled to present at
the Canaccord Genuity Growth Conference in Boston.
(Logo: http://photos.prnewswire.com/prnh/20120528/535447
)
|
Conference:
|
Canaccord
Genuity Growth Conference
|
|
Date:
|
Thursday,
August 16, 2012
|
|
Time:
|
10:00 a.m.
ET
|
The presentation will be webcast live over the Internet and can
be accessed through the Investor Relations section on Syneron's
website at www.investors.syneron.com. Please go to the website a
few minutes early, as it may be necessary to download audio
software to hear the presentation.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global
aesthetic device company with a comprehensive product portfolio and
a global distribution footprint. The Company's technology enables
physicians to provide advanced solutions for a broad range of
medical-aesthetic applications including body contouring, hair
removal, wrinkle reduction, rejuvenation of the skin's appearance
through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The
Company sells its products under two distinct brands, Syneron and
Candela. Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and
manufacturing operations in the US. The Company markets, services
and supports its products in 90 countries. It has offices in
North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
SOURCE Syneron Medical Ltd.